Ethan C. Whipp

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia”.

VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia

Leukemia(2022)10.1038/s41375-022-01758-z

N/A

0.546DataRank · unranked

37 citations

Ethan C. Whipp, Janek S. Walker, Pu Zhang, Larry Beaver, Katie Williams +21 more

The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloid leukemia via inhibition of Wnt/β-catenin signaling

Experimental Hematology and Oncology(2024)10.1186/s40164-024-00483-w

N/A

0DataRank · unranked

12 citations

Madeline Halpin, Dominique Corbin, Yerdanos Asemelash, Steven Sher, Britten Gordon +17 more